Biology:SLITRK6

From HandWiki
Short description: Protein-coding gene in the species Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

SLIT and NTRK-like protein 6 is a protein that in humans is encoded by the SLITRK6 gene.[1][2]

Function

Members of the SLITRK family, such as SLITRK6, are integral membrane proteins with 2 N-terminal leucine-rich repeat (LRR) domains similar to those of SLIT proteins (see SLIT1). Most SLITRKs, including SLITRK6, also have C-terminal regions that share homology with neurotrophin receptors (see NTRK1). SLITRKs are expressed predominantly in neural tissues and have neurite-modulating activity.[1][2]

Clinical significance

Mutations in SLITRK6 cause high myopia and deafness in humans and mice.[3]

As a drug target

The protein is the target for the antibody-drug conjugate ASG-15ME which is in phase 1 clinical trials for urothelial cancer.[4]

References

  1. 1.0 1.1 "Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue". Gene 315: 87–94. Oct 2003. doi:10.1016/S0378-1119(03)00715-7. PMID 14557068. 
  2. 2.0 2.1 "Entrez Gene: SLITRK6 SLIT and NTRK-like family, member 6". https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=84189. 
  3. "SLITRK6 mutations cause myopia and deafness in humans and mice". J. Clin. Invest. 123 (5): 2094–102. 2013. doi:10.1172/JCI65853. PMID 23543054. 
  4. Seattle Genetics and Agensys, an Affiliate of Astellas (October 2016). "Interim Analysis of a Phase 1 Dose Escalation Trial of ASG-22CE (ASG-22ME; enfortumab vedotin), an Antibody-Drug Conjugate (ADC) in Patients with Metastatic Urothelial Cancer". Poster Abstract #788P, European Society for Medical Oncology (ESMO) Congress, Copenhagen. http://www.businesswire.com/news/home/20161007005357/en/Seattle-Genetics-Agensys-Affiliate-Astellas-Highlight-Promising. 

Further reading